Inhibitors of protease-activated receptor-2
US10550089B2 · kind B2 · utility
1Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 11, 2017 |
| Grant date | Feb 4, 2020 |
| Priority date | — |
| Expiry date | May 11, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4164
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to certain substituted imidazole and triazole compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating pain, musculoskeletal inflammation, neuroinflammatory disorders, airway inflammation, itch, dermatitis, colitis and related conditions. The compounds are of Formula (I) where X is N or CH, Z and Y are N or C (but both not N) and R1-R3 are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.